Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: A longitudinal analysis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Mutimura, Eugene ^a   Hoover, Donald R ^b   Shi, Qiuhu ^c   Dusingize, Jean Claude ^a   Sinayobye, Jean D'Amour ^a   Cohen, Mardge ^d   Anastos, Kathryn ^e  

^a Regional Alliance for Sustainable Development (RASD Rwanda) Kigali   (Rwanda)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d Stroger Hospital   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; GLUCOSE; INSULIN; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EXPOSURE; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; RWANDAN; TREATMENT DURATION; WEIGHT CHANGE; WOMEN'S HEALTH; ADVERSE EFFECTS; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RWANDA;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MIDDLE AGED; PROSPECTIVE STUDIES; RWANDA;

EID: 84928138047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123936     Document Type: Article

References (30)

1. Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J et al. Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study. J Acquir Immune Defic Syndr 2008; 49: 369-376. PMID: 19186350
2. Idiculla J, Ravindra'n GD, D'Souza J, Singh G, Furrugh S. Diabetes mellitus, insulin resistance, and metabolic syndrome in HIV-positive patients in South India. Int J Gen Med 2011; 4: 73-78. doi: 10.2147/IJGM.S15818 PMID: 21403795
3. De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C et al. Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31: 1224-1229. doi: 10.2337/dc07-2013 PMID: 18268071
4. Dave JA, Lambert EV, Badri M, West S, Maartens G, Levitt NS. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients. J Acquir Immune Defic Syndr 2011; 57: 284-289. doi: 10.1097/QAI.0b013e318221863f PMID: 21602696
5. Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM et al. Protease Inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 298-302. PMID: 12626890
6. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165: 1179-1184. PMID: 15911733
7. UNAIDS. UNAIDS report on the global AIDS epidemic: 2010. 2010 www.unaids.org/documents/20101123-globalreport-em.pdf (22 July 2014, date last assessed)
8. Shao Y, Williamson C. The HIV-1 Epidemic: Low- to Middle-Income Countries. Cold Spring Harb Perspect Med 2012; 2: a007187. doi: 10.1101/cshperspect.a007187 PMID: 22393534
9. Kalra S, Agrawal N. Diabetes and HIV: current understanding and future perspectives. Curr Diab Rep 2013; 13: 419-427. doi: 10.1007/s11892-013-0369-9 PMID: 23446780
10. Kiage JN, Heimburger DC, Nyirenda CK, Wellons MF, Bagchi S, Chi BH et al. Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Lipids Health Dis 2013; 12: 50. doi: 10.1186/1476-511X-12-50 PMID: 23575345
11. Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W et al. Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti- HIV Drugs (D:A:D Study). Circulation 2009; 119: 805-811. doi: 10.1161/CIRCULATIONAHA.108.790857 PMID: 19188509
12. Thienemann F, Sliwa F, Rockstroh JK. HIV and the heart: the impact of antiretroviral therapy: a global perspective. Eur Heart J 2013; 34: 3538-3546. doi: 10.1093/eurheartj/eht388 PMID: 24126882
13. Dusingize JC, Hoover DR, Shi Q, Mutimura E, Kiefer E, Anastos K. Associations of HIV infection with insulin and glucose levels in antiretroviral-naïve Rwandan women. BMJ Open 2013; 3: e003879. doi: 10.1136/bmjopen-2013-003879 PMID: 24319275
14. Kiefer E, Hoover DR, Shi Q, Dusingize JC, Cohen M, Mutimura E et al. Association of pre-treatment nutritional status with change in CD4+ cell count after antiretroviral therapy at 6, 12, and 24 months in Rwandan women. PLoS One 2011; 6:e29625. doi: 10.1371/journal.pone.0029625 PMID: 22216334
15. Dusingize JC, Hoover DR, Shi Q, Mutimura E, Kiefer E, Cohen M et al. Association of serum albumin with markers of nutritional status among HIV-infected and uninfected Rwandan women. PLoS One 2012; 7:e35079. doi: 10.1371/journal.pone.0035079 PMID: 22532840
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. PMID: 3899825
17. Henderson M, Rabasa-Lhoret R, Bastard JP, Chiasson JL, Baillargeon JP, Hanley JA et al. Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method? Diabetes Metab 2011; 37: 72-78. doi: 10.1016/j.diabet.2010.06.008 PMID: 21126900
18. Kotler DP, Burastero S, Wang J, Pierson RN, Jr. Prediction of body cell mass and total body water using bioimpedance analysis: effects of race, gender, and disease. Am J Clin Nutr 1996; 64(3 Suppl):489S-497S. PMID: 8780369
19. Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyard M et al. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. I Int AIDS Soc 2012; 15:17426. doi: 10.7448/IAS.15.2.17426 PMID: 23078769
20. Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P et al. Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther 2012; 17:19-100. doi: 10.3851/IMP1916 PMID: 22267465
21. Danoff A, Shi Q, Justman J, Mulligan K, Hessol N, Robison E et al. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. J Acquir Immune Defic Syndr 2005; 39: 55-62. PMID: 15851914
22. Butt AA, McGinnis K, Rodriguez-Barradas MC, Crystal S, Simberkoff M, Goetz MB et al. HIV infection and the risk of diabetes. AIDS 2009; 23: 1227-1234. doi: 10.1097/QAD.0b013e32832bd7af PMID: 19444074
23. Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Creon D et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS 2012; 26: 303-314. doi: 10.1097/QAD.0b013e32834e8776 PMID: 22089377
24. Brar I, Shuter J, Thomas A, Daniels E, Absalon. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr 2007; 45: 66-71. PMID: 17245229
25. Menezes C, Crowther N, Duarte R, Van Amsterdam D, Evans D, Dickens C et al. A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients. HIV Med 2014; 15: 3-12. doi: 10.1111/hiv.12074 PMID: 23980620
26. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, Hirschel B et al. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 2007; 45: 111-119. PMID: 17554711
27. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperetore G et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000; 15; 151: 190-198. PMID: 10645822
28. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63. PMID: 10857969
29. Senn S. Change from baseline and analysis of covariance revisited. Stat Med 2006; 25:4334-4344. PMID: 16921578
30. Maruthur NM. The growing prevalence of type 2 diabetes: increased incidence or improved survival?Curr Diab Rep 2013; 13: 786-794. doi: 10.1007/s11892-013-0426-4 PMID: 24072478